# COHANCE share price, delivery % and history — Cohance Lifesciences Limited

> Delivery percentage for Cohance Lifesciences Limited (COHANCE) against its own history, with 1,627 sessions of split-adjusted NSE data from 2020 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/COHANCE

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 444 INR (-3.04% on the day), 2026-09-30
- Delivery: 64.06% of volume taken to demat (20-day average 48.22%)
- Volume: 14.80L shares, turnover ₹65.7Cr
- Relative volume: 1.19× of its own 20-day average

## Technicals

- RSI(14): 47.34
- ATR(14): 17.61
- SMA 50: 445.25, SMA 200: 416.76
- 52-week range: 266.7 – 917.85 (-51.63% from the high)

## Performance

- 1 week -3.78%, 1 month -2.62%, 3 months -1.9%
- 6 months 46.68%, 1 year -50.63%

## Delivery percentage

- Latest: 64.06% (2026-09-30)
- 20-day average: 48.22%
- 1-year average: 45.2%
- Percentile against its own history: 71th
- Range: 5.45% – 100% across 1,621 sessions with a reading

Over the last 20 sessions COHANCE settled 48.2% of its traded quantity, which is above average for an NSE equity. Its one-year average is 45.2%, so recent sessions are running 3.0 points higher than usual. The latest session ranks higher than 71% of the 1,621 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 16,987.3 crore
- P/E (TTM): 161.89 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 2.74 INR, split-adjusted to match the price series
- Revenue growth: -23.13% YoY, -31.8% QoQ
- Profit growth: -197.39% YoY, -643.8% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 3y | 25.88% | -37.23% |
| 4y | 17.84% | -30.75% |
| 5y | 21.05% | -22.52% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 257.7 | 172.3 | 99.5 | 82 | 3.23 | 31.81% |
| 2024-12-31 | 307.2 | 213.1 | 109.7 | 83.3 | 3.26 | 27.12% |
| 2025-03-31 | 402 | 361 | 51.6 | 38.7 | 1.65 | 9.63% |
| 2025-06-30 | 549.3 | 492.6 | 62.8 | 46.4 | 1.28 | 8.45% |
| 2025-09-30 | 555.6 | 487.4 | 83.8 | 66.4 | 1.94 | 11.95% |
| 2025-12-31 | 544.6 | 505.3 | 40.6 | 29 | 0.96 | 5.33% |
| 2026-03-31 | 619.1 | 580.9 | 19.9 | 8.3 | 0.51 | 1.34% |
| 2026-06-30 | 422.3 | 477.4 | -42.9 | -45.2 | -0.63 | -10.7% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 57.49%
- Public: 42.51%
- FII: 6.5%, DII: 20.09%
- Promoter shares pledged: 94.56%

## Recent filings

- 2026-08-05: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_182888_05082026201308_iXBRL_WEB.html
- 2026-07-17: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1695778_17072026082832_WEB.xml
- 2026-05-12: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_157064_12052026210322_iXBRL_WEB.html
- 2026-04-21: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1656383_21042026050916_WEB.xml
- 2026-02-12: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142721_12022026211206_iXBRL_WEB.html
- 2026-01-21: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1607146_21012026043514_WEB.xml
- 2025-11-12: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_127002_12112025221108_iXBRL_WEB.html
- 2025-10-16: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1550889_16102025071521_WEB.xml

Dated by the day the company broadcast the filing. 55 events are indexed for this instrument.

## About the instrument

- Listed: 2020-03-09 — latest session 2026-09-30 (1,627 sessions)
- ISIN: INE03QK01018
- Series: EQ
- Liquidity rank: #436 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/COHANCE.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.